hI-con1

· Iconic Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for hI-con1, covering 2020-09-24 to 2020-09-24. Get the full timeline:

Most recent: Clinical Trial Update: Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration [Phase 2]

See pricing